CD99: A Cell Surface Protein with an Oncojanus Role in Tumors

被引:60
|
作者
Manara, Maria Cristina [1 ]
Pasello, Michela [1 ]
Scotlandi, Katia [1 ]
机构
[1] Rizzoli Orthopaed Inst, CRS Dev Biomol Therapies, Lab Expt Oncol, I-40136 Bologna, Italy
来源
GENES | 2018年 / 9卷 / 03期
关键词
CD99; tumor progression; antibodies; targeted therapies; EWINGS-SARCOMA CELLS; PRIMITIVE NEUROECTODERMAL TUMORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER CELLS; MIC2; EXPRESSION; MEMBRANE-PROTEIN; DOWN-REGULATION; SPLICE VARIANT; IMMUNOREACTIVITY; ENGAGEMENT;
D O I
10.3390/genes9030159
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cell surface molecule CD99 has gained interest because of its involvement in regulating cell differentiation and adhesion/migration of immune and tumor cells. However, the molecule plays an intriguing and dual role in different cell types. In particular, it acts as a requirement for cell malignancy or as an oncosuppressor in tumors. In addition, the gene encodes for two different isoforms, which also act in opposition inside the same cell. This review highlights key studies focusing on the dual role of CD99 and its isoforms and discusses major critical issues, challenges, and strategies for overcoming those challenges. The review specifically underscores the properties that make the molecule an attractive therapeutic target and identifies new relationships and areas of study that may be exploited. The elucidation of the spatial and temporal control of the expression of CD99 in normal and tumor cells is required to obtain a full appreciation of this molecule and its signaling.
引用
收藏
页数:17
相关论文
共 50 条
  • [21] FLI1 and CD99 staining in primitive neuroectodermal tumors arising in association with testicular germ cell tumors
    Henley, JD
    Ulbright, TM
    Michael, H
    MODERN PATHOLOGY, 2003, 16 (01) : 153A - 153A
  • [22] Regulation of osteoblast differentiation: The pivotal role of CD99 molecule
    Sciandra, Marika
    Marino, Maria Teresa
    Manara, Maria Cristina
    Lucarelli, Enrico
    Grano, Maria
    Picci, Piero
    Scotlandi, Katia
    CANCER RESEARCH, 2011, 71
  • [23] Regulation of MHC class I expression: Role of CD99
    Ghislaine, B
    Albano, L
    Alberti, I
    Pourtein, M
    Bernard, A
    GENES AND IMMUNITY, 2003, 4 : S14 - S14
  • [24] O13 (CD99) reactivity in Merkel cell carcinoma and basaloid cutaneous adnexal tumors
    Nicholson, S
    McDermott, MB
    Swanson, PE
    Wick, MR
    MODERN PATHOLOGY, 1998, 11 (01) : 52A - 52A
  • [25] Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99
    Jonas Mattisson
    Marcus Danielsson
    Maria Hammond
    Hanna Davies
    Caroline J. Gallant
    Jessica Nordlund
    Amanda Raine
    Malin Edén
    Lena Kilander
    Martin Ingelsson
    Jan P. Dumanski
    Jonatan Halvardson
    Lars A. Forsberg
    Scientific Reports, 11
  • [26] CD99 REGULATES NORMAL AND MALIGNANT HEMATOPOIETIC STEM CELL FUNCTION BY RESTRICTING PROTEIN TRANSLATION
    Chung, Stephen
    Hu, Wenhuo
    Guo, Liang
    Park, Christopher
    EXPERIMENTAL HEMATOLOGY, 2018, 64 : S58 - S59
  • [27] Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder
    Yanhua Xuan
    Seokhyung Kim
    Zhenhua Lin
    Journal of Cancer Research and Clinical Oncology, 2011, 137 : 49 - 54
  • [28] CD99 isoforms dictate T cell functional outcomes
    Alberti, I
    Bernard, G
    Jazdanian, AKR
    Pelassy, C
    Monique, P
    Aussel, C
    Bernard, A
    FASEB JOURNAL, 2003, 17 (07): : C4 - C5
  • [29] Protein expression and gene promoter hypermethylation of CD99 in transitional cell carcinoma of urinary bladder
    Xuan, Yanhua
    Kim, Seokhyung
    Lin, Zhenhua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2011, 137 (01) : 49 - 54
  • [30] Immunoexpression of inhibin α subunit, inhibin/activin βA subunit and CD99 in ovarian tumors
    Choi, YL
    Kim, HS
    Ahn, G
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2000, 124 (04) : 563 - 569